A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 2, 2012, Pages 296-302

  Wen, Hao ^a,b   Wu, Xiaohua ^a,b   Li, Ziting ^a,b   Wang, Huaying ^a,b   Zang, Rongyu ^a,b   Sun, Min ^a,b   Huang, Xiao ^a,b   Zhang, Zhiyi ^a,b   Cai, Shumo ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Brachytherapy; Cervical cancer; Chemotherapy; Neoadjuvant treatment; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84863271635     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31823610a1     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Parkin M, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24:S11-S25.
3. Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl1):S43-S103.
4. Choi YS, Sin JI, Kim JH, et al. Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer. J Korea Med Sci. 2006;21:683-689. (Pubitemid 44199324)
5. Cai HB, Chen HZ, Yin HH. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J Obstet Gynaecol Res. 2006;32:315-323.
6. Yamakawa Y, Fujimura M, Hidaka T, et al. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Gynecol Oncol. 2000;77:264-270. (Pubitemid 30317147)
7. Calais G, Le Floch O, Chauvet B, et al. Carcinoma of the uterine cervix stage IB and early IIB. Prognostic value of the histological tumor regression after initial brachytherapy. Int J Radiat Oncol Biol Phys. 1989;17:1231-1235. (Pubitemid 20028641)
8. Toita T, Sakumoto K, Higashi M, et al. Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced uterine cervical cancer. Gynecol Oncol. 1997;65:421-424. (Pubitemid 27255981)
9. Perez CA, Grigsby PW, Camel HM, et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 1995;31:703-716.
10. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205-216. (Pubitemid 30099779)
11. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Metaanalysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer. 2003;39:2470-2486.
12. Eddy GL, Bundy BN, Creasman WT, et al. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007;106:362-369. (Pubitemid 47087936)
13. Raspagliesi F, Ditto A, Selvaggi L, et al. A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2010;20:1569-1575.
14. Hwang Y, Jung S, Kim S, et al. Cisplatin and etoposide as neoadjuvant chemotherapy in patients with stage IIB-IIIB cervical cancer: a phase II study. Gynecol Oncol. 2010;116:92.
15. Selvaggi L, Loizzi V, Di Gilio AR, et al. Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience. Int J Gynecol Cancer. 2006;16:631-637.
16. Scarabelli C, Zarreli A, Gallo A, et al. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer. A preliminary study. Cancer. 1995;76:1019-1026
17. Ueda M, Ueki K, Kumagai K, et al. Neoadjuvant intra-arterial infusion chemotherapy induces apoptotic cell death in locally advanced uterine cervical carcinomas. A preliminary report. Int J Gynecol Cancer. 1998;8:144-149. (Pubitemid 28246520)
18. Kobayashi K, Furukawa A, Takahashi M, et al. Neoadjuvant intra-arterial chemotherapy for locally advanced uterine cervical cancer: Clinical efficacy and factors influencing response. Cardiovasc Intervent Radio. 2003;26:234-241. (Pubitemid 37022410)
19. Ishikawa H, Kikkawa F, Tamakoshi K, et al. Distribution of platinum in human genecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy. Anticancer Res. 1996;16:3849-3853. (Pubitemid 27085060)
20. Terai Y, Kanemura M, Sasaki H, et al. Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer. Int J Clin Oncol. 2009;14:56-62.
21. Kim HS, Kim JY, Park NH, et al. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer. Gynecol Oncol. 2010;119:217-224.
22. Chen H, Liang C, Zhang L, et al. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study. Gynecol Oncol. 2008;110:308-315.
23. Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2010;(1):CD007406.
24. Pinheiro W, Pereira AKC, Soares JM, et al. Is the combination of mitomycin C, bleomycin and methotrexate effective as a neoadjuvant treatment for cervical cancer in women? Eur J Gynaecol Oncol. 2011,32:37-39.
25. Mori T, Hosokawa K, Sawada M, et al. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer long-term results. Int J Gynecol Cancer. 2010;20:611-616.